Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $224.24B as of Saturday, August 1, 2026.
ENTERPRISE VALUE (EV)
$224.24B
Novo Nordisk A/S
Market Cap
$209.19B
Enterprise Value (EV)
$224.24B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Novo Nordisk A/S (NVO) | $209.19B | $224.24B |
| Amgen Inc. (AMGN)vs › | $207.87B | $253.16B |
| Thermo Fisher Scientific Inc. (TMO)vs › | $213.42B | $251.91B |
| Abbott Laboratories (ABT)vs › | $184.11B | $211.61B |
| Gilead Sciences, Inc. (GILD)vs › | $161.66B | $176.21B |
| Pfizer Inc. (PFE)vs › | $142.54B | $205.29B |
| Danaher Corporation (DHR)vs › | $137.13B | $159.34B |
| Bristol-Myers Squibb Company (BMY)vs › | $133.37B | $167.77B |
| CVS Health Corp. (CVS)vs › | $133.25B | $202.05B |
| AstraZeneca PLC (AZN)vs › | $131.47B | $157.83B |
Market Cap
$209.19B
Total Debt
$19.20B
Cash
$4.15B
Enterprise Value
$224.24B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
